Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Alopecia areata.

Lloyd E King¹, Kevin J McElwee, John P Sundberg

¹Division of Dermatology, Vanderbilt University Medical Center, Nashville, TN 37203, USA. lloyd.king@vanderbilt.edu

Current Directions in Autoimmunity

|May 8, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nonsurgical Induction of Alopecia Areata in C3H/HeJ Mice via Adoptive Transfer of Cultured Lymphoid Cells.

Methods in molecular biology (Clifton, N.J.)·2026

Same author

Role of <i>Aire</i> and <i>Notch4</i> allelic mutations in alopecia areata in C3H/HeJ mice.

JID innovations : skin science from molecules to population health·2026

Same author

Immune therapies for alopecia areata: evidence and new perspectives.

Expert review of clinical immunology·2025

Same author

Harmonizing mouse anatomy terminology: a common language?

Mammalian genome : official journal of the International Mammalian Genome Society·2025

Same author

Errors in pathology: The real world.

Veterinary pathology·2025

Same author

American Hair Research Society Mentorship Grant Program: Short-Term Training Opportunities with Experts.

The Journal of investigative dermatology·2025

Same journal

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.

Current directions in autoimmunity·2010

Same journal

TNF in host resistance to tuberculosis infection.

Current directions in autoimmunity·2010

Same journal

TNF-alpha and obesity.

Current directions in autoimmunity·2010

Same journal

TNF and bone.

Current directions in autoimmunity·2010

Same journal

TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.

Current directions in autoimmunity·2010

Same journal

T cells as sources and targets of TNF: implications for immunity and autoimmunity.

Current directions in autoimmunity·2010

See all related articles

Recent advances in immunology and genetics have improved understanding of alopecia areata (AA) pathogenesis. A new mouse model significantly accelerates AA onset, aiding research into causes and treatments for this autoimmune skin condition.

Area of Science:

Immunology
Dermatology
Genetics

Background:

Alopecia areata (AA) is an organ-specific, cell-mediated autoimmune disease.
Understanding AA pathogenesis has significantly advanced due to progress in immunology, genetics, and technology.

Purpose of the Study:

To summarize recent advances in alopecia areata (AA) research.
To highlight the utility of the C3H/HeJ mouse model for studying AA.
To discuss the implications of these advances for identifying AA subtypes, understanding disease mechanisms, and developing new therapies.

Main Methods:

Review of recent immunological and genetic research in AA.
Utilizing the C3H/HeJ mouse model for AA studies.
Application of advanced technologies in RNA, DNA, proteomics, and computational analysis.

Related Experiment Videos

Main Results:

The C3H/HeJ mouse model, particularly with skin grafts, provides a highly reproducible system for studying AA onset and mechanisms.
Methodological and genetic advances facilitate the identification of AA subtypes in both mice and humans.
Progress enables better characterization of disease mechanisms and development of improved treatments.

Conclusions:

Continued research into gene mutations and signaling pathways will yield further insights into AA pathogenesis and therapy.
Advances in understanding AA are expected to benefit research into other organ-specific autoimmune diseases.
The development of new therapies for AA is anticipated in the coming decade.